U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757867) titled 'Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata' on Aug. 06.
Brief Summary: This study planned to measure the effectiveness and safety of microneedling aided administration of cetirizine 1% versus latanoprost 0.01% in alopecia areata.
Study Start Date: Oct. 01, 2022
Study Type: INTERVENTIONAL
Condition:
Microneedling-Assisted Delivery
Cetirizine
Latanoprost
Alopecia Areata
Intervention:
DRUG: Cetirizine (Zyrtec)
Patinets treated with microneedling-aided administration of topical cetirizine 1% solution
DRUG: Latanoprost
Patients treated with microneedling-aided administration of topical tr...